Because treatment of the whole prostate can lead to long-term side effects in patients with prostate cancer, interest in ...

Patients with early-stage Hodgkin lymphoma had impressive response rates when treated with a novel combination of ...

Patients newly diagnosed with PAH are often undertreated relative to treatment recommendations outlined in current guidelines.

The results of the phase 3 MajesTEC-9 trial showcase teclistamab's efficacy for patients with relapsed/refractory multiple ...

Targeted therapies, including BTK inhibitors and venetoclax, have replaced chemoimmunotherapy as the first-line standard for CLL, emphasizing patient preference and risk factors in treatment decisions ...

This clinical overview details the latest evidence-based strategies for diagnosing and treating symptoms of benign prostatic hyperplasia in men.